Altamira Therapeutics Ltd. (NASDAQ:CYTO – Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 444,500 shares, an increase of 620.4% from the March 15th total of 61,700 shares. Based on an average daily volume of 1,140,000 shares, […]
Shares of Altamira Therapeutics Ltd. (CYTO) are up 48% on Monday following the company's announcement of a collaboration with Univercells Group. CYTO is trading on the Nasdaq at $2.
Altamira Therapeutics Ltd. (NASDAQ:CYTO – Get Free Report)’s stock price fell 2.2% on Thursday . The company traded as low as $1.80 and last traded at $1.81. 46,922 shares changed hands during trading, a decline of 76% from the average session volume of 192,669 shares. The stock had previously closed at $1.85. Altamira Therapeutics Stock […]
By Chris Wack Altamira Therapeutics shares were up 13% at $2.38 after the company filed a second provisional patent application with the U.S. Patent and.
By Dean Seal Shares of Altamira Therapeutics more than doubled after the company said it would partially spin off its subsidiary that produces the allergy.